Century Therapeutics (IPSC) Change in Account Payables (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Change in Account Payables data on file, last reported at -$1.6 million in Q1 2026.

• On a quarterly basis, Change in Account Payables fell 550.14% year-over-year to -$1.6 million in Q1 2026; TTM through Mar 2026 was -$424000.0, a 76.41% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, up 206.33% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$1.6 million, down from $2.2 million in the prior quarter.
• Over the last five years, Change in Account Payables for IPSC reached as high as $4.0 million in Q3 2023 and fell as low as -$3.0 million in Q1 2023.
• Historically, Change in Account Payables has averaged -$510647.1 across 5 years, with a median of -$591000.0 in 2025.
• Across the five-year window, Change in Account Payables surged 465.72% in 2023 and plunged 550.14% in 2026, its largest moves.
• Year by year, Change in Account Payables stood at -$1.6 million in 2022, then sank by 76.79% to -$2.9 million in 2023, then jumped by 116.52% to $477000.0 in 2024, then soared by 352.2% to $2.2 million in 2025, then slumped by 175.34% to -$1.6 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$1.6 million in Q1 2026, $2.2 million in Q4 2025, and -$591000.0 in Q3 2025.